EPISODE · Mar 25, 2008 · 12 MIN
The Lancet: March 25, 2008
from Listen to The Lancet · host The Lancet
Josef Smolen from the Medical University of Vienna, Austria, discusses in this week's podcast how the monoclonal antibody tocilizumab could be effective in treating rheumatoid arthritis. Tocilizumab blocks interleukin 6, a pro-inflammatory cytokine involved in the biological process behind rheumatoid arthritis
Embed this episode
NOW PLAYING
The Lancet: March 25, 2008
0:00
12:31
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet?
This episode is 12 minutes long.
When was this Listen to The Lancet episode published?
This episode was published on March 25, 2008.
Can I download this Listen to The Lancet episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!